A constitutional predisposition to breast cancer-related lymphoedema and effect of axillary lymph node surgery on forearm muscle lymph flow.

[1]  B. Newman,et al.  Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. , 2013, The Lancet. Oncology.

[2]  B. Schmidt,et al.  Lymphatic and Angiogenic Candidate Genes Predict the Development of Secondary Lymphedema following Breast Cancer Surgery , 2013, PloS one.

[3]  N. Foroughi,et al.  Normative volume difference between the dominant and nondominant upper limbs in healthy older women. , 2012, Lymphatic research and biology.

[4]  A. Spurdle,et al.  Possible genetic predisposition to lymphedema after breast cancer. , 2012, Lymphatic research and biology.

[5]  K. Alitalo,et al.  The lymphatic vasculature in disease , 2011, Nature Medicine.

[6]  Alberto Smith,et al.  Mutations in FOXC2 in Humans (Lymphoedema Distichiasis Syndrome) Cause Lymphatic Dysfunction on Dependency , 2011, Journal of Vascular Research.

[7]  K. Alitalo,et al.  Growth Factor Therapy and Autologous Lymph Node Transfer in Lymphedema , 2011, Circulation.

[8]  K. Alitalo,et al.  Lymphangiogenesis: Molecular Mechanisms and Future Promise , 2010, Cell.

[9]  P. Mortimer,et al.  Recent advances in breast cancer-related lymphedema of the arm: lymphatic pump failure and predisposing factors. , 2009, Lymphatic research and biology.

[10]  Michael J Kallan,et al.  Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  P. Mortimer,et al.  Lymphatic drainage in the muscle and subcutis of the arm after breast cancer treatment , 2009, Breast Cancer Research and Treatment.

[12]  Ilsa Nielsen,et al.  Breast cancer-related lymphoedema risk reduction advice: a challenge for health professionals. , 2008, Cancer treatment reviews.

[13]  P. Mortimer,et al.  Clinical assessment of human lymph flow using removal rate constants of interstitial macromolecules: a critical review of lymphoscintigraphy. , 2007, Lymphatic research and biology.

[14]  A. Purushotham,et al.  Lymphatic transfer studies with immunoglobulin scintigraphy after axillary surgery. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  W. Svensson,et al.  Human lymphatic pumping measured in healthy and lymphoedematous arms by lymphatic congestion lymphoscintigraphy , 2007, The Journal of physiology.

[16]  S. Duffy,et al.  Lymph Node Status and Breast Cancer-related Lymphedema , 2007, Annals of surgery.

[17]  U. Chetty,et al.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. , 2006, Journal of the National Cancer Institute.

[18]  W. Svensson,et al.  A quantitative lymphoscintigraphic evaluation of lymphatic function in the swollen hands of women with lymphoedema following breast cancer treatment. , 2006, Clinical science.

[19]  Sheryl G. A. Gabram,et al.  Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial , 2006, Annals of Surgical Oncology.

[20]  B. Pockaj,et al.  Breast cancer-related lymphedema. , 2005, Mayo Clinic proceedings.

[21]  M. Leivonen,et al.  The consequences of long‐time arm morbidity in node‐negative breast cancer patients with sentinel node biopsy or axillary clearance , 2005, Journal of surgical oncology.

[22]  J. Sitzia,et al.  Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. , 2005, QJM : monthly journal of the Association of Physicians.

[23]  P. Mortimer,et al.  Regional distribution of epifascial swelling and epifascial lymph drainage rate constants in breast cancer-related lymphedema. , 2005, Lymphatic research and biology.

[24]  K. Devriendt,et al.  Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. , 2003, American journal of human genetics.

[25]  P. Mortimer,et al.  An audit of the incidence of arm lymphoedema after prophylactic level I/II axillary dissection without division of the pectoralis minor muscle. , 2003, Annals of the Royal College of Surgeons of England.

[26]  W. Svensson,et al.  Impairment of lymph drainage in subfascial compartment of forearm in breast cancer-related lymphedema. , 2003, Lymphatic research and biology.

[27]  W. Svensson,et al.  Differences in lymph drainage between swollen and non-swollen regions in arms with breast-cancer-related lymphoedema. , 2001, Clinical science.

[28]  K. Devriendt,et al.  Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. , 2000, American journal of human genetics.

[29]  S. Rockson.  Precipitating factors in lymphedema: Myths and realities , 1998, Cancer.

[30]  N. Willich,et al.  Lymphoedema of the arm after primary treatment of breast cancer. , 1998, Anticancer Research.

[31]  D. Strachan,et al.  The prevalence of arm oedema following treatment for breast cancer , 1996 .

[32]  D. Bates,et al.  Change in macromolecular composition of interstitial fluid from swollen arms after breast cancer treatment, and its implications. , 1993, Clinical science.

[33]  P. Mortimer.  Investigation and management of lymphoedema , 1990 .